Idebenone + Idebenone + Placebo
Phase 3Completed 0 views this week 0 watching💤 Quiet
Interest: 30/100
30
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Friedreich's Ataxia
Conditions
Friedreich's Ataxia
Trial Timeline
Dec 1, 2007 → Apr 1, 2009
NCT ID
NCT00537680About Idebenone + Idebenone + Placebo
Idebenone + Idebenone + Placebo is a phase 3 stage product being developed by Santhera Pharmaceuticals for Friedreich's Ataxia. The current trial status is completed. This product is registered under clinical trial identifier NCT00537680. Target conditions include Friedreich's Ataxia.
What happened to similar drugs?
0 of 6 similar drugs in Friedreich's Ataxia were approved
Approved (0) Terminated (0) Active (6)
Hype Score Breakdown
Clinical
17
Activity
8
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00537680 | Phase 3 | Completed |
Competing Products
11 competing products in Friedreich's Ataxia
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Interferon γ-1b | Amgen | Phase 3 | 40 |
| interferon γ-1b | Amgen | Phase 3 | 40 |
| Interferon γ-1b + Placebo | Amgen | Phase 3 | 40 |
| varenicline + placebo | Pfizer | Phase 2/3 | 30 |
| Lu AA24493 + Placebo | Lundbeck | Phase 2 | 32 |
| Omeveloxolone | Biogen | Pre-clinical | 30 |
| Placebo + EPI-743 400 mg + EPI-743 200 mg | PTC Therapeutics | Phase 2 | 32 |
| SGT-212 | Solid Biosciences | Phase 1 | 30 |
| idebenone + Placebo | Santhera Pharmaceuticals | Phase 3 | 30 |
| Idebenone | Santhera Pharmaceuticals | Phase 3 | 30 |
| Idebenone + Placebo | Santhera Pharmaceuticals | Phase 3 | 30 |